AN32A_HUMAN - dbPTM
AN32A_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID AN32A_HUMAN
UniProt AC P39687
Protein Name Acidic leucine-rich nuclear phosphoprotein 32 family member A
Gene Name ANP32A
Organism Homo sapiens (Human).
Sequence Length 249
Subcellular Localization Nucleus. Cytoplasm. Endoplasmic reticulum. Translocates to the cytoplasm during the process of neuritogenesis (By similarity). Shuttles between nucleus and cytoplasm..
Protein Description Implicated in a number of cellular processes, including proliferation, differentiation, caspase-dependent and caspase-independent apoptosis, suppression of transformation (tumor suppressor), inhibition of protein phosphatase 2A, regulation of mRNA trafficking and stability in association with ELAVL1, and inhibition of acetyltransferases as part of the INHAT (inhibitor of histone acetyltransferases) complex. Plays a role in E4F1-mediated transcriptional repression..
Protein Sequence MEMGRRIHLELRNRTPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSIANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYDRDDKEAPDSDAEGYVEGLDDEEEDEDEEEYDEDAQVVEDEEDEDEEEEGEEEDVSGEEEEDEEGYNDGEVDDEEDEEELGEEERGQKRKREPEDEGEDDD
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
12MethylationRRIHLELRNRTPSDV
CCEEEECCCCCHHHH
22.62-
15PhosphorylationHLELRNRTPSDVKEL
EEECCCCCHHHHHHH
30.6023927012
17PhosphorylationELRNRTPSDVKELVL
ECCCCCHHHHHHHHH
55.1923927012
20UbiquitinationNRTPSDVKELVLDNS
CCCHHHHHHHHHCCC
50.7721890473
20AcetylationNRTPSDVKELVLDNS
CCCHHHHHHHHHCCC
50.7725953088
27PhosphorylationKELVLDNSRSNEGKL
HHHHHCCCCCCCCCC
36.4323401153
29PhosphorylationLVLDNSRSNEGKLEG
HHHCCCCCCCCCCCC
38.7725159151
68UbiquitinationPKLNKLKKLELSDNR
CCCCCCCCCCCCCCC
58.59-
75MethylationKLELSDNRVSGGLEV
CCCCCCCCCCHHHHH
29.03-
77PhosphorylationELSDNRVSGGLEVLA
CCCCCCCCHHHHHHH
24.7321815630
86UbiquitinationGLEVLAEKCPNLTHL
HHHHHHHHCCCCCEE
49.76-
86AcetylationGLEVLAEKCPNLTHL
HHHHHHHHCCCCCEE
49.7625953088
87S-nitrosylationLEVLAEKCPNLTHLN
HHHHHHHCCCCCEEE
1.712212679
96PhosphorylationNLTHLNLSGNKIKDL
CCCEEECCCCCCCCH
38.9772255823
99UbiquitinationHLNLSGNKIKDLSTI
EEECCCCCCCCHHHC
55.4421890473
99AcetylationHLNLSGNKIKDLSTI
EEECCCCCCCCHHHC
55.4425953088
101UbiquitinationNLSGNKIKDLSTIEP
ECCCCCCCCHHHCHH
54.98-
101AcetylationNLSGNKIKDLSTIEP
ECCCCCCCCHHHCHH
54.9819608861
104PhosphorylationGNKIKDLSTIEPLKK
CCCCCCHHHCHHHHH
37.1630266825
105PhosphorylationNKIKDLSTIEPLKKL
CCCCCHHHCHHHHHH
36.3428857561
110UbiquitinationLSTIEPLKKLENLKS
HHHCHHHHHHHCCCC
67.0621890473
110SuccinylationLSTIEPLKKLENLKS
HHHCHHHHHHHCCCC
67.0623954790
110AcetylationLSTIEPLKKLENLKS
HHHCHHHHHHHCCCC
67.0623749302
116UbiquitinationLKKLENLKSLDLFNC
HHHHHCCCCCCCCCC
61.63-
117PhosphorylationKKLENLKSLDLFNCE
HHHHCCCCCCCCCCE
30.2220873877
123GlutathionylationKSLDLFNCEVTNLND
CCCCCCCCEECCHHH
3.3122555962
123S-nitrosylationKSLDLFNCEVTNLND
CCCCCCCCEECCHHH
3.3119483679
123S-nitrosocysteineKSLDLFNCEVTNLND
CCCCCCCCEECCHHH
3.31-
126PhosphorylationDLFNCEVTNLNDYRE
CCCCCEECCHHHHHH
16.2221406692
131PhosphorylationEVTNLNDYRENVFKL
EECCHHHHHHHHHHH
20.8221406692
132MethylationVTNLNDYRENVFKLL
ECCHHHHHHHHHHHH
31.70-
132DimethylationVTNLNDYRENVFKLL
ECCHHHHHHHHHHHH
31.70-
137UbiquitinationDYRENVFKLLPQLTY
HHHHHHHHHHHHHHC
44.85-
143PhosphorylationFKLLPQLTYLDGYDR
HHHHHHHHCCCCCCC
19.4526356563
144PhosphorylationKLLPQLTYLDGYDRD
HHHHHHHCCCCCCCC
16.0426356563
148PhosphorylationQLTYLDGYDRDDKEA
HHHCCCCCCCCCCCC
13.8925884760
150MethylationTYLDGYDRDDKEAPD
HCCCCCCCCCCCCCC
45.61-
158PhosphorylationDDKEAPDSDAEGYVE
CCCCCCCCCCCCCCC
37.3526657352
163PhosphorylationPDSDAEGYVEGLDDE
CCCCCCCCCCCCCCC
6.1926074081
204PhosphorylationEGEEEDVSGEEEEDE
CCCCCCCCCCHHHCC
53.4615287743
238AcetylationEERGQKRKREPEDEG
HHHHHHCCCCCCCCC
69.0526051181
238MethylationEERGQKRKREPEDEG
HHHHHHCCCCCCCCC
69.05-

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
158SPhosphorylationKinaseCSNK2A1P68400
GPS
158SPhosphorylationKinaseCK2-FAMILY-GPS
158SPhosphorylationKinaseCK2_GROUP-PhosphoELM
204SPhosphorylationKinaseCSNK2A1P68400
GPS
204SPhosphorylationKinaseCK2-FAMILY-GPS
204SPhosphorylationKinaseCK2_GROUP-PhosphoELM

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of AN32A_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of AN32A_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
MAP1B_HUMANMAP1Bphysical
12807913
XPO1_HUMANXPO1physical
11565755
TAF1A_HUMANTAF1Aphysical
11163245
SET_HUMANSETphysical
11163245
SET_HUMANSETphysical
17142970
H31_HUMANHIST1H3Aphysical
15100215
IMA5_HUMANKPNA1physical
16713569
IMA6_HUMANKPNA5physical
16713569
IMA7_HUMANKPNA6physical
16713569
PRGR_HUMANPGRphysical
15308690
THB_HUMANTHRBphysical
15308690
PPARG_HUMANPPARGphysical
15308690
PCBP1_HUMANPCBP1physical
21988832
ARC1B_HUMANARPC1Bphysical
22863883
IF4A3_HUMANEIF4A3physical
22863883
PDLI5_HUMANPDLIM5physical
22863883
RFA2_HUMANRPA2physical
22863883
LA_HUMANSSBphysical
22863883
TPD54_HUMANTPD52L2physical
22863883
PFD3_HUMANVBP1physical
22863883
SAHH2_HUMANAHCYL1physical
26344197
AN32B_HUMANANP32Bphysical
26344197
AN32E_HUMANANP32Ephysical
26344197
DMAP1_HUMANDMAP1physical
26344197
PAPP1_HUMANPAPPAphysical
26344197
DCAF1_HUMANVPRBPphysical
26344197
VPS72_HUMANVPS72physical
26344197
ELAV1_HUMANELAVL1physical
11565755

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of AN32A_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-15 AND SER-17, AND MASSSPECTROMETRY.
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry.";
Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.;
Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-158, AND MASSSPECTROMETRY.

TOP